End-of-day quote
Pakistan S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
222.5
PKR
|
-1.57%
|
|
-1.29%
|
+0.86%
|
Fiscal Period: June |
2021
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
12,781
|
5,949
|
9,674
|
-
|
Enterprise Value (EV)
1 |
12,781
|
5,949
|
9,674
|
9,674
|
P/E ratio
|
30.7
x
|
21.9
x
|
8.46
x
|
6.23
x
|
Yield
|
-
|
-
|
1.75%
|
2.38%
|
Capitalization / Revenue
|
-
|
0.52
x
|
0.49
x
|
0.42
x
|
EV / Revenue
|
-
|
0.52
x
|
0.49
x
|
0.42
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
43,469
|
43,469
|
43,469
|
-
|
Reference price
2 |
294.0
|
136.8
|
222.5
|
222.5
|
Announcement Date
|
8/31/21
|
10/7/23
|
-
|
-
|
Fiscal Period: June |
2021
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
11,457
|
19,615
|
23,001
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
1,001
|
-
|
-
|
Operating Margin
|
-
|
8.73%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
1,173
|
271.3
|
-
|
-
|
Net margin
|
-
|
2.37%
|
-
|
-
|
EPS
2 |
9.592
|
6.240
|
26.30
|
35.70
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
3.900
|
5.300
|
Announcement Date
|
8/31/21
|
10/7/23
|
-
|
-
|
Fiscal Period: June |
2021
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/31/21
|
10/7/23
|
-
|
-
|
Last Close Price
222.5
PKR Average target price
325
PKR Spread / Average Target +46.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.86% | 34.74M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|